retatrutide ly3437943 glp-1 gip glucagon receptor agonist triple mechanism Beyond GLP -1: Retatrutide's triple-agonist (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based Cagrilintide vs Retatrutide Compared |
Pay in 4 interest-free payments of $7.47 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30







:max_bytes(150000):strip_icc()/VWH-GettyImages-1140651585-bd0de08b4eec4945872f679fc8926bfb.jpg)



















